Oncology & Cancer

Why Hodgkin's lymphoma cells grow uncontrollably

Although classical Hodgkin's lymphoma is generally easily treatable today, many aspects of the disease still remain a mystery. A team at the Max Delbrück Center led by Professor Claus Scheidereit has now identified an important ...

Oncology & Cancer

Old drugs bring new hope to a cancer that lacks precision therapy

An estimated 15 to 20 percent of all breast cancer patients are "triple negative." These unfortunate women lack three crucial treatment targets—the estrogen receptor, the progesterone receptor and human epidermal growth ...

page 2 from 23